Animal Pharm is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Companion Animals

Set Alert for Companion Animals

Jaguar submits final major regulatory filing for FDA Canalevia approval

Jaguar Health has tendered its last key regulatory application towards US approval of Canalevia for chemotherapy-induced diarrhea (CID) in dogs.

Canine Pharmaceuticals

Signals suggest V-shaped recovery occurring in US vet practice market

US investment bank William Blair said a healthy rebound is occurring in veterinary practice revenues.

Markets Companion Animals

USDA unable to verify COVID-19 infection in pug

A dog in North Carolina previously suspected of being infected by COVID-19 likely never had the virus, according to the USDA. 

Companion Animals North America

KindredBio fast-tracked parvovirus program will be firm's first mAb approval in 2021

Kindred Biosciences expects its next US approval to be for its canine parvovirus monoclonal antibody (mAb) in early 2021.

Kindred Biosciences R&D

Carus continues innovation scouting as bacteriophage and technology projects enter next stages

Carus Animal Health has a mandate to search for innovation that it can take from the human healthcare sector into animal health. Despite the coronavirus pandemic, the company has made headway with some of its key partnerships. Animal Pharm editor Joseph Harvey had a virtual chat with Carus commercial director Jolian Howell to find out the latest progress.

Companion Animals R&D

New Animal Pharm special report looks at animal care growth drivers 2020-2030

The quest for animal health innovation has accelerated tremendously over recent years, as leading players develop strategies to offset the maturation of product portfolios.

Antiparasitics Diagnostics

Vetoquinol feline combination antiparasitic generic gains US approval

The US FDA has approved Vetoquinol's parasiticide Imoxi Topical Solution for Cats.

United States Vetoquinol

Zomedica opens $20m public offering of shares

Zomedica Pharmaceuticals is seeking around $20 million from a public offering of shares.

Diagnostics Companion Animals

Survey highlights uptake of telehealth, importance of continuous product supply

A survey has found the most negative impact of the COVID-19 pandemic on veterinary practices has been in clinic visits and over-the-counter (OTC) medications. 

Operations Companion Animals

Germany reports first COVID-19 cat infection, additional case in France

There have been two new reports of COVID-19 virus infection in pets in the past few weeks, according to the OIE.

Europe Companion Animals

Anivive files request to repurpose feline drug for COVID-19 in humans

US firm Anivive Lifesciences has submitted an application to the US FDA to repurpose its GC376 feline drug for COVID-19 in humans.

Pharmaceuticals Feline

Companion animal industry's continuing digital revolution is being sped up by coronavirus

While the trend of digitally focused business in animal health started to grow before COVID-19, the companion animal sector is now witnessing an even greater uptake of technology.

Companion Animals Equipment & Technology
See All
UsernamePublicRestriction

Register